Influence of C3 deficiency on atherosclerosis

Circulation

Volumn 105, Issue 25, 2002, Pages 3025-3031

  Buono, Chiara ^a   Come, Carolyn E ^a   Witztum, Joseph L ^a   Maguire, Graham F ^a   Connelly, Philip W ^a   Carroll, Michael ^a   Lichtman, Andrew H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Atherosclerosis; Complement; Inflammation

Indexed keywords

CHOLESTEROL; COMPLEMENT COMPONENT C3; IMMUNOGLOBULIN; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; COMPLEMENT DEFICIENCY; COMPLEMENT SYSTEM; CONTROLLED STUDY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE ASSAY;

ANIMALS; AORTA; ARTERIOSCLEROSIS; COMPLEMENT C3; IMMUNOGLOBULINS; LIPOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHENOTYPE; RECEPTORS, LDL;

EID: 0037173016     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000019584.04929.83     Document Type: Article

References (30)

1. Atherosclerosis: An inflammatory disease
2. Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex
3. The role of complement in B cell activation and tolerance
4. Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity
5. Regulation of the B cell response to T-dependent antigens by classical pathway complement
6. Are immunological mechanisms relevant for the development of atherosclerosis?
7. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis: Clinical significance determined in a follow-up study
8. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis
9. Immunization of LDL receptor deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes
10. Complement activation and atherosclerosis
11. Cells carrying C5b-9 complement complexes in human atherosclerotic wall
12. Immunohistochemical demonstration of enzymatically modified human LDL and its colocalization with the terminal complement complex in the early atherosclerotic lesion
13. Complement components, but not complement inhibitors, are upregulated in atherosclerotic plaques
14. Accumulation of IgG and complement factor C3 in human arterial endothelium and atherosclerotic lesions
15. Generation of C-reactive protein and complement components in atherosclerotic plaques
16. Complement and atherogenesis: Binding of CRP to degraded, nonoxidized LDL enhances complement activation
17. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries
18. The oxidation hypothesis of atherosclerosis
19. Complement C6 deficiency protects against diet-induced atherosclerosis in rabbits
20. -/- mice develop atherosclerosis in the absence of complement component c5
21. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery
22. Monoclonal antibodies to complement components without the need of their prior purification, II: Antibodies to mouse C3 and C4
23. Hyperlipidemia and atherosclerotic lesion development in LDL receptor-deficient mice fed defined semipurified diets with and without cholate
24. Reduction of atherosclerosis in mice by inhibition of CD40 signalling
25. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques
26. Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins
27. Acylation stimulating protein (ASP), an adipocyte autocrine: New directions
28. A critical evaluation of the putative role of C3adesArg (ASP) in lipid metabolism and hyperapobetalipoproteinemia
29. Genetic deficiency of acylation stimulating protein (ASP(C3ades-Arg)) does not cause hyperapobetalipoproteinemia in mice
30. Sublytic C5b-9 induces proliferation of human aortic smooth muscle cells: Role of mitogen activated protein kinase and phosphatidylinositol 3-kinase